Juventas
is a biotechnology company that discovers and develops non-viral gene therapies for the treatment of chronic cardiovascular diseases... Read moreJuventas
is a biotechnology company that discovers and develops non-viral gene therapies for the treatment of chronic cardiovascular diseases... Read more
News
Sep 16, 2019
ChinaBio Today
Juventas: CASI Files for China Trials of CD19 CAR-T Candidate
Jun 17, 2019
Contract Pharma
Juventas: CASI Acquires Anti-CD19 T-cell Therapy from Juventas
Dec 03, 2018
StreetInsider
Press Release: Juventas : Merchavia's Portfolio Company 'Juventas' Announces Strategic Commercialization Agreement
Nov 22, 2018
FirstWord Pharma
Juventas: Astellas Executes License Agreement with an Option to Acquire JVS-100 Gene Therapy Program from Juventas
Aug 18, 2018
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Nov 02, 2017
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 17102017 Prices from USD $250
Oct 02, 2017
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 22082017 Prices from USD $250
May 10, 2017
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 26042017 Prices from USD $250
Apr 19, 2017
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Updated 20032017 Prices from USD $250
Jan 18, 2017
BioPortfolio
Juventas: Juventas Therapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Juventas Competitors
1
2
3
4
5
6
7
8
9
10